Here he is also responsible for Clinical Hemostaseology with a focus on autoimmune and coagulation disorders and leading the interdisciplinary hemostaseology consultancy service.

His particular research area comprises translational rheumatologic/clinical immunology studies with a tracking record on B lineage cells in autoimmunity and identifying new treatment targets and strategies. He has also a proven record as PI in developing new concepts and implementing innovative immune therapies in autoimmune diseases. Most of his studies in early clinical development (Phase I/FIH to Phase IIa/b) have been performed with Charité Research Organization Berlin with a dedicated phase I unit.